Johnson & Johnson MedTech‘s  Medical today announced one-year results in a study using its Javelin peripheral IVL catheter.

Johnson & Johnson MedTech‘s Shockwave Medical today announced one-year results supporting the use of its Shockwave peripheral ...

ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model ...

“Cutting balloon angioplasty is a reasonable and less costly option when compared with intravascular lithotripsy for the ...

As an adjunct to bypass surgery for ischemic cardiomyopathy, a cardiac shockwave therapy aimed at regenerating ischemic myocardium boosted left ventricular ejection fraction (LVEF) and physical ...

Medical device manufacturer Shockwave Medical is set to acquire Canada-based cardiovascular device manufacturer Neovasc for $75 million. Shockwave will purchase outstanding Neovasc shares for $27.25 ...

(Reuters) -Johnson & Johnson on Friday agreed to buy Shockwave Medical in a deal valued at $13.1 billion including debt, as it builds its cardiac-health-centric medical devices business to help drive ...

(Bloomberg) -- Johnson & Johnson agreed to acquire Shockwave Medical Inc. for about $13.1 billion to bolster its expansion into making medical devices to treat heart disease. J&J will pay $335 a share ...

Shockwave Medical Inc (NASDAQ:SWAV) shares are trading lower after the released Q3 earnings. Q3 revenue was $186.0 million, a 42% increase, beating the consensus of $184.72 million, primarily driven ...

Shockwave’s R&D team meet with CEO Doug Godshall (seated, center) weekly to assess the progress of current projects and pitch new ideas. BY FastCo Works Cardiologists have long been confounded by a ...